DISCOVERING DEVELOPING DELIVERING HOPE

Mezzion Pharma Co., Ltd.

Application Filed: 2018-11-08
Trademark Application Details
Trademark Logo DISCOVERING DEVELOPING DELIVERING HOPE

The mark consists of stylized "DISCOVERING" "DEVELOPING" "DELIVERING HOPE" with a dot on either side of "DEVELOPING".

Mark For: DISCOVERING DEVELOPING DELIVERING HOPE® trademark registration is intended to cover the categories of educational services, namely, seminars in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues and distribution of course materials in connection therewith; providing a website featuring blogs in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues. [all]

>Color is not claimed as a feature of the mark. The mark consists of stylized "DISCOVERING" "DEVELOPING" "DELIVERING HOPE" with a dot on either side of "DEVELOPING".

Status

2021-04-07 UTC
LIVE APPLICATION Published for Opposition
A pending trademark application has been examined by the Office and has been published in a way that provides an opportunity for the public to oppose its registration.


Research OneLook Acronym Finder
Serial Number88186713
Registration Number6337607
Mark Literal ElementsDISCOVERING DEVELOPING DELIVERING HOPE
Mark Drawing Type3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark TypeSERVICE MARK
Standard Character ClaimNo
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2021-01-14
Basis44(e)
Class StatusACTIVE
Primary US Classes
  • 100: Miscellaneous
  • 101: Advertising and Business
  • 107: Education and Entertainment
Primary International Class
  • 041 - Primary Class
  • (Education and entertainment) Education; providing of training; entertainment; sporting and cultural activities.
Filed UseNo
Current UseNo
Intent To UseNo
Filed ITUYes
44D FiledNo
44E CurrentYes
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameHoward M. Gitten
Attorney Docket Number40836-6030US
Law Office AssignedL40
Employee NameMARTIN, CHRISTINE C

Timeline

2018-11-08Application Filed
2019-08-02Location: TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED
2019-08-02Status: Live/Pending
2019-08-02Transaction Date
2020-03-26Trademark Registered
2021-01-14Location: PUBLICATION AND ISSUE SECTION
2021-02-16Published
2021-02-16Status: Application has been published for opposition. The opposition period begins on the date of publication.
2021-05-04Trademark Registered

Trademark Parties (Applicants & Owners)

Party: Mezzion Pharma Co., Ltd.
AddressC & H Building, 3rd Floor, 35 Teheran-ro 87-Gil, Gangnam-Gu Seoul KOREA, REPUBLIC OF 06167
Legal Entity TypeLimited Company (ltd.)
Legal Entity StateKOREA, REPUBLIC OF

Documents

DrawingJPEG2018-11-08
TEAS RF New ApplicationMULTI2018-11-08
Design Search Code Corr ProjectAPPLICATION/XML2018-11-28
XSearch Search SummaryAPPLICATION/XML2019-01-23
Offc Action OutgoingMULTI2019-01-24
Response to Office ActionMULTI2019-07-24
Amendment and Mail Process CompleteMULTI2019-08-01
Suspension LetterXML2019-08-02
Suspension InquiryXML2020-02-10
TEAS Response to Suspension InquiryMULTI2020-06-12
Amendment and Mail Process CompleteAPPLICATION/XML,IMAGE/JPEG2020-06-17
Amendment to Delete or Correct BasisMULTI2020-06-17
Offc Action OutgoingXML2020-06-30
Response to Office ActionAPPLICATION/XML2020-12-28
Amendment and Mail Process CompleteAPPLICATION/XML,IMAGE/JPEG2020-12-29
TRAM Snapshot of App at Pub for OppostnAPPLICATION/XML,IMAGE/JPEG2021-01-05
Notice of PublicationXML2021-01-27
Notification Of Notice of PublicationXML2021-01-27
OG Publication ConfirmationAPPLICATION/XML2021-02-16

Design Search Codes

26.01.21Circles that are totally or partially shaded.
260113Circles, two (not concentric); Two circles
260121Circles that are totally or partially shaded.

Attorney of Record

HOWARD M. GITTEN
LEWIS BRISBOIS BISGAARD & SMITH, LLP
550 WEST ADAMS STREET, SUITE 300
CHICAGO, IL 60661

Good, Services, and Codes


IC 041. US 100 101 107. G & S: Educational services, namely, seminars in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues and distribution of course materials in connection therewith; providing a website featuring blogs in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues
IC 042. US 100 101. G & S: Medical and pharmaceutical research for the treatment of cardiac disease and disorders; Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and product development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders research, and single ventricle heart disease (SVHD) research, including SVHD subjects who have undergone Fontan Palliation; for medical research purposes; conducting clinical trials for others; providing a website featuring medical and scientific research information in the field of pharmaceuticals and medicine
IC 044. US 100 101. G & S: Providing websites featuring information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medicine, health, wellness, and cardiac health issues; Medical testing and screening services, namely, medical diagnostic testing services and medical screening for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; providing a website featuring information in the field of health and wellness; providing a website featuring medical information in the field of cardiac issues; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation for diagnostic or treatment purposes

International Codes:41
U.S. Codes:100,101,107
International Codes:42
U.S. Codes:100,101
International Codes:44
U.S. Codes:100,101
Type CodeType
CC0000Color is not claimed as a feature of the mark.
CC0000Color is not claimed as a feature of the mark.

Trademark Filing History

DescriptionDateProceeding Number
PUBLISHED FOR OPPOSITION2021-02-16
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2021-02-16
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2021-01-27
ELECTRONIC RECORD REVIEW COMPLETE2021-01-1479148
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED2021-01-08
APPROVED FOR PUB - PRINCIPAL REGISTER2021-01-04
TEAS/EMAIL CORRESPONDENCE ENTERED2020-12-2888889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2020-12-28
CORRESPONDENCE RECEIVED IN LAW OFFICE2020-12-2888889
NOTIFICATION OF NON-FINAL ACTION E-MAILED2020-06-306325
NON-FINAL ACTION WRITTEN2020-06-3085324
NON-FINAL ACTION E-MAILED2020-06-306325
TEAS/EMAIL CORRESPONDENCE ENTERED2020-06-1669712
CORRESPONDENCE RECEIVED IN LAW OFFICE2020-06-1669712
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED2020-06-12
SUSPENSION INQUIRY WRITTEN2020-02-1085324
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED2020-02-10
LIE CHECKED SUSP - TO ATTY FOR ACTION2020-02-1069712
INQUIRY TO SUSPENSION E-MAILED2020-02-10
SUSPENSION LETTER WRITTEN2019-08-0285324
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED2019-08-026332
LETTER OF SUSPENSION E-MAILED2019-08-026332
TEAS/EMAIL CORRESPONDENCE ENTERED2019-07-3169712
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-07-3169712
ASSIGNED TO LIE2019-07-2969712
TEAS RESPONSE TO OFFICE ACTION RECEIVED2019-07-24
NOTIFICATION OF NON-FINAL ACTION E-MAILED2019-01-246325
NON-FINAL ACTION WRITTEN2019-01-2485324
NON-FINAL ACTION E-MAILED2019-01-246325
ASSIGNED TO EXAMINER2019-01-2285324
NOTICE OF DESIGN SEARCH CODE E-MAILED2018-11-28
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-11-27
NEW APPLICATION ENTERED IN TRAM2018-11-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed